PhorMed
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1999 Avenue of the Stars Ste 1100, Los A...Website
www.phormed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About PhorMed
PhorMed, Inc. is a biopharmaceutical company dedicated to developing and commercializing RP-323, a targeted cell repair immunotherapy aimed at reducing inflammation for the treatment of neurological diseases, cancer, and inflammatory lung disorders such as Acute Respiratory Distress Syndrome (ARDS). The company focuses on redefining treatment standards by creating safer and more effective therapies that restore damaged cells and alleviate harmful inflammation. PhorMed serves patients battling life-threatening diseases and collaborates with clinical partners to advance its innovative pipeline. With ongoing clinical studies and a commitment to ethical business practices, PhorMed is positioned for significant growth and innovation in the healthcare sector.Explore more
Popular SearchesPhormed IncPhorMedSIC Code 28,283NAICS Code 32,325Show more
PhorMed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PhorMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at PhorMed
Check if PhorMed has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PhorMed launches new products
Earning: See what the market has to say on PhorMed recently announced quarterly report
Check out if PhorMed is spiking on competitors!
Click to see if PhorMed had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
PhorMed, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once PhorMed has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined PhorMed as Masked Content
Find more new buyers
Compare Similar Companies to PhorMed
Compare insights from companies similar to PhorMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PhorMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PhorMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PhorMed.
PhorMed Tech Stack
A closer look at the technologies used by PhorMed
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PhorMed
Sign Up For FreeTo access detailed company insights
PhorMed, Inc. is a biopharmaceutical company dedicated to developing and commercializing RP-323, a targeted cell repair immunotherapy aimed at reducing inflammation for the treatment of neurological diseases, cancer, and inflammatory lung disorders such as Acute Respiratory Distress Syndrome (ARDS). The company focuses on redefining treatment stand... Read More
